175 related articles for article (PubMed ID: 20980102)
1. RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice.
Ohsawa M; Aasato M; Hayashi SS; Kamei J
Pain; 2011 Jan; 152(1):114-122. PubMed ID: 20980102
[TBL] [Abstract][Full Text] [Related]
2. Role of DLC2 and RhoA/ROCK pathway in formalin induced inflammatory pain in mice.
Wong SSC; Lee UM; Wang XM; Chung SK; Cheung CW
Neurosci Lett; 2019 Sep; 709():134379. PubMed ID: 31323253
[TBL] [Abstract][Full Text] [Related]
3. Involvement of inhibition of RhoA/Rho kinase signaling in simvastatin-induced amelioration of neuropathic pain.
Ohsawa M; Ishikura K; Mutoh J; Hisa H
Neuroscience; 2016 Oct; 333():204-13. PubMed ID: 27457035
[TBL] [Abstract][Full Text] [Related]
4. Mevalonate sensitizes the nociceptive transmission in the mouse spinal cord.
Ohsawa M; Mutoh J; Hisa H
Pain; 2008 Feb; 134(3):285-292. PubMed ID: 17764839
[TBL] [Abstract][Full Text] [Related]
5. RhoA/Rho kinase signaling in the spinal cord and diabetic painful neuropathy.
Ohsawa M; Kamei J
Eur J Pharmacol; 2010 Oct; 644(1-3):1-4. PubMed ID: 20655903
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
7. Saikosaponin d (SSD) alleviates diabetic peripheral neuropathy by regulating the AQP1/RhoA/ROCK signaling in streptozotocin-induced diabetic rats.
Xiang Q; Liu Y; Chen L
Acta Diabetol; 2023 Jun; 60(6):805-815. PubMed ID: 36920548
[TBL] [Abstract][Full Text] [Related]
8. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
Bivalacqua TJ; Champion HC; Usta MF; Cellek S; Chitaley K; Webb RC; Lewis RL; Mills TM; Hellstrom WJ; Kadowitz PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9121-6. PubMed ID: 15184671
[TBL] [Abstract][Full Text] [Related]
9. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.
Islam MZ; Van Dao C; Miyamoto A; Shiraishi M
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):929-938. PubMed ID: 28656320
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin attenuated cerebrovascular cell proliferation in the development of hypertension through Rho/Rho-kinase pathway.
Ma MM; Li SY; Wang M; Guan YY
J Cardiovasc Pharmacol; 2012 Jun; 59(6):576-82. PubMed ID: 22392066
[TBL] [Abstract][Full Text] [Related]
12. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
13. P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.
Jing F; Zhang Y; Long T; He W; Qin G; Zhang D; Chen L; Zhou J
J Neuroinflammation; 2019 Nov; 16(1):217. PubMed ID: 31722730
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Rho/Rho kinase pathway prevents lipopolysaccharide-induced hyperalgesia and the release of TNF-α and IL-1β in the mouse spinal cord.
Wang C; Song S; Zhang Y; Ge Y; Fang X; Huang T; Du J; Gao J
Sci Rep; 2015 Sep; 5():14553. PubMed ID: 26416580
[TBL] [Abstract][Full Text] [Related]
15. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
16. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
[TBL] [Abstract][Full Text] [Related]
17. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
18. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
Serra N; Rosales R; Masana L; Vallvé JC
PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
Hunter JC; Zeidan A; Javadov S; Kilić A; Rajapurohitam V; Karmazyn M
J Mol Cell Cardiol; 2009 Dec; 47(6):810-8. PubMed ID: 19799911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
